Pregen
1 known investors
PreGen applies artificial intelligence to gene expression data to develop clinically validated prognostic and predictive molecular tests for cancer patients, starting with prostate cancer. Its tests run on standard PCR equipment with results delivered via a web platform, designed for decentralized deployment in emerging countries, with a focus on Latin America.
Founders & leadership
DA
Daniel AlonsoinCo-Founder
Investors · 1
Frequently asked questions
- What does Pregen do?
- PreGen applies artificial intelligence to gene expression data to develop clinically validated prognostic and predictive molecular tests for cancer patients, starting with prostate cancer. Its tests run on standard PCR equipment with results delivered via a web platform, designed for decentralized deployment in emerging countries, with a focus on Latin America.
- Who founded Pregen?
- Pregen was founded by Daniel Alonso.
- Who are Pregen's investors?
- Pregen's investors include GRIDX.